431 related articles for article (PubMed ID: 33763698)
1. YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner.
Feng M; Xie X; Han G; Zhang T; Li Y; Li Y; Yin R; Wang Q; Zhang T; Wang P; Hu J; Cheng Y; Gao Z; Wang J; Chang J; Cui M; Gao K; Chai J; Liu W; Guo C; Li S; Liu L; Zhou F; Chen J; Zhang H
Blood; 2021 Jul; 138(1):71-85. PubMed ID: 33763698
[TBL] [Abstract][Full Text] [Related]
2. YBX1 mediates translation of oncogenic transcripts to control cell competition in AML.
Perner F; Schnoeder TM; Xiong Y; Jayavelu AK; Mashamba N; Santamaria NT; Huber N; Todorova K; Hatton C; Perner B; Eifert T; Murphy C; Hartmann M; Hoell JI; Schröder N; Brandt S; Hochhaus A; Mertens PR; Mann M; Armstrong SA; Mandinova A; Heidel FH
Leukemia; 2022 Feb; 36(2):426-437. PubMed ID: 34465866
[TBL] [Abstract][Full Text] [Related]
3. The m6A reader IGF2BP3 promotes acute myeloid leukemia progression by enhancing RCC2 stability.
Zhang N; Shen Y; Li H; Chen Y; Zhang P; Lou S; Deng J
Exp Mol Med; 2022 Feb; 54(2):194-205. PubMed ID: 35217832
[TBL] [Abstract][Full Text] [Related]
4. METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m
Weng H; Huang H; Wu H; Qin X; Zhao BS; Dong L; Shi H; Skibbe J; Shen C; Hu C; Sheng Y; Wang Y; Wunderlich M; Zhang B; Dore LC; Su R; Deng X; Ferchen K; Li C; Sun M; Lu Z; Jiang X; Marcucci G; Mulloy JC; Yang J; Qian Z; Wei M; He C; Chen J
Cell Stem Cell; 2018 Feb; 22(2):191-205.e9. PubMed ID: 29290617
[TBL] [Abstract][Full Text] [Related]
5. YBX1 regulates the survival of chronic myeloid leukemia stem cells by modulating m
Chai J; Wang Q; Qiu Q; Han G; Chen Y; Li W; Zhang H
Cell Oncol (Dordr); 2023 Apr; 46(2):451-464. PubMed ID: 36512307
[TBL] [Abstract][Full Text] [Related]
6. YBX1 expression and function in early hematopoiesis and leukemic cells.
Bhullar J; Sollars VE
Immunogenetics; 2011 Jun; 63(6):337-50. PubMed ID: 21369783
[TBL] [Abstract][Full Text] [Related]
7. YBX1 as an oncogenic factor in T-cell acute lymphoblastic leukemia.
Li H; Zhang D; Fu Q; Wang S; Wang Z; Zhang X; Chen X; Zhu X; An N; Chen Y; Zhou L; Lu D; Zhao N
Blood Adv; 2023 Sep; 7(17):4874-4885. PubMed ID: 37339496
[TBL] [Abstract][Full Text] [Related]
8. N
Cheng Y; Xie W; Pickering BF; Chu KL; Savino AM; Yang X; Luo H; Nguyen DT; Mo S; Barin E; Velleca A; Rohwetter TM; Patel DJ; Jaffrey SR; Kharas MG
Cancer Cell; 2021 Jul; 39(7):958-972.e8. PubMed ID: 34048709
[TBL] [Abstract][Full Text] [Related]
9. LNCAROD is stabilized by m6A methylation and promotes cancer progression via forming a ternary complex with HSPA1A and YBX1 in head and neck squamous cell carcinoma.
Ban Y; Tan P; Cai J; Li J; Hu M; Zhou Y; Mei Y; Tan Y; Li X; Zeng Z; Xiong W; Li G; Li X; Yi M; Xiang B
Mol Oncol; 2020 Jun; 14(6):1282-1296. PubMed ID: 32216017
[TBL] [Abstract][Full Text] [Related]
10. RNA-binding proteins as drivers of AML and novel therapeutic targets.
Qin T; Cheng Y; Wang X
Leuk Lymphoma; 2022 May; 63(5):1045-1057. PubMed ID: 35075986
[TBL] [Abstract][Full Text] [Related]
11. TTC5 is required to prevent apoptosis of acute myeloid leukemia stem cells.
Lynch JT; Somerville TD; Spencer GJ; Huang X; Somervaille TC
Cell Death Dis; 2013 Apr; 4(4):e573. PubMed ID: 23559008
[TBL] [Abstract][Full Text] [Related]
12. [Methyltransferase-like 3 Promotes the Proliferation of Acute Myeloid Leukemia Cells by Regulating N6-methyladenosine Levels of MYC].
Wang XS; He JR; Yu S; Yu J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Jun; 40(3):308-314. PubMed ID: 29978784
[TBL] [Abstract][Full Text] [Related]
13. m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization in Acute Myeloid Leukemia.
Du A; Wu X; Gao Y; Jiang B; Wang J; Zhang P; Zhao Q
Front Immunol; 2021; 12():789914. PubMed ID: 34887874
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic inhibition of GAS6-AS1/YBX1/MYC axis suppresses cell propagation and disease progression of acute myeloid leukemia.
Zhou H; Liu W; Zhou Y; Hong Z; Ni J; Zhang X; Li Z; Li M; He W; Zhang D; Chen X; Zhu J
J Exp Clin Cancer Res; 2021 Nov; 40(1):353. PubMed ID: 34753494
[TBL] [Abstract][Full Text] [Related]
15. The N6-methyladenosine RNA modification in acute myeloid leukemia.
Yankova E; Aspris D; Tzelepis K
Curr Opin Hematol; 2021 Mar; 28(2):80-85. PubMed ID: 33337619
[TBL] [Abstract][Full Text] [Related]
16. The RNA m6A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression.
Hong YG; Yang Z; Chen Y; Liu T; Zheng Y; Zhou C; Wu GC; Chen Y; Xia J; Wen R; Liu W; Zhao Y; Chen J; Gao X; Chen Z
Cancer Res; 2023 Mar; 83(6):845-860. PubMed ID: 36634204
[TBL] [Abstract][Full Text] [Related]
17. RNA-binding protein IGF2BP3 targeting of oncogenic transcripts promotes hematopoietic progenitor proliferation.
Palanichamy JK; Tran TM; Howard JM; Contreras JR; Fernando TR; Sterne-Weiler T; Katzman S; Toloue M; Yan W; Basso G; Pigazzi M; Sanford JR; Rao DS
J Clin Invest; 2016 Apr; 126(4):1495-511. PubMed ID: 26974154
[TBL] [Abstract][Full Text] [Related]
18. High Wilms' tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m
Naren D; Yan T; Gong Y; Huang J; Zhang D; Sang L; Zheng X; Li Y
J Cancer Res Clin Oncol; 2021 Jan; 147(1):33-47. PubMed ID: 32880751
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
Zhao X; Liu Y; Yu S
Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
[TBL] [Abstract][Full Text] [Related]
20. The mRNA m6A reader YTHDF2 suppresses proinflammatory pathways and sustains hematopoietic stem cell function.
Mapperley C; van de Lagemaat LN; Lawson H; Tavosanis A; Paris J; Campos J; Wotherspoon D; Durko J; Sarapuu A; Choe J; Ivanova I; Krause DS; von Kriegsheim A; Much C; Morgan M; Gregory RI; Mead AJ; O'Carroll D; Kranc KR
J Exp Med; 2021 Mar; 218(3):. PubMed ID: 33156926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]